Appili Therapeutics
(OTC) APLIF
Appili Therapeutics Financials at a Glance
Market Cap
$1.62M
Revenue (TTM)
$206.22K
Net Income (TTM)
$2.96M
EPS (TTM)
$-0.02
P/E Ratio
-0.73
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$0.01
Volume
2,520
Open
$0.01
Price
$0.01
Volume
2,520
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.03
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$0.01
Volume
2,520
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.03
APLIF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Appili Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Don Cilla, MBA
Website
www.appilitherapeutics.comHeadquarters
Halifax, NS B3H 0A8, CA
APLIF Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-15%
Net Income Margin
-14%
Return on Equity
0%
Return on Capital
20%
Return on Assets
-5%
Earnings Yield
-1.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.62M
Shares Outstanding
128.37M
Volume
2.52K
Short Interest
0.00%
Avg. Volume
18.72K
Financials (TTM)
Gross Profit
$100.44K
Operating Income
$190.84K
EBITDA
$360.57K
Operating Cash Flow
$868.82K
Capital Expenditure
$2.36K
Free Cash Flow
$866.46K
Cash & ST Invst.
$1.23M
Total Debt
$12.29M
Appili Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$114.89K
+6.0%
Gross Profit
$115.01K
+6.1%
Gross Margin
1.00%
N/A
Market Cap
$1.62M
N/A
Market Cap/Employee
$202.18K
N/A
Employees
8
N/A
Net Income
$948.73K
-80.9%
EBITDA
$716.73K
-8635.2%
Quarterly Fundamentals
Net Cash
$12.24M
-10.3%
Accounts Receivable
$179.01K
-89.8%
Inventory
$0.00
N/A
Long Term Debt
$736.20K
-9.3%
Short Term Debt
$11.71M
+11.9%
Return on Assets
-5.40%
N/A
Return on Invested Capital
20.00%
N/A
Free Cash Flow
$292.83K
+33.9%
Operating Cash Flow
$292.83K
+33.8%